Patient P-02523
Synthetic patientMETA-24 · Day 170 · 35–44 · F · baseline S17Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
18%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S17
- Day 148 BR-03 recommended — Behavioural Recommendation BR-03
- Day 149 Patient declined — Not now
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity+17
- GI instability-13
- Nutritional resilience+10
- Treatment adherence+2
What helped?
- Behavioural Recommendation BR-03Day 148Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable72 min
stable · -1.7 vs previous 14 d
Sleep duration
Wearable6.8 h
stable · -0.3 vs previous 14 d
Energy level
Daily log5.4/10
worsening · -0.3 vs previous 14 d
Steps
Wearable7,052
worsening · -403 vs previous 14 d
GI burden
Companion20.1/100
worsening · +10.9 vs previous 14 d
Adherence
Companion93.5 %
stable · +2.7 vs previous 14 d
Sleep quality
Wearable49.3/100
worsening · -5.8 vs previous 14 d
Glucose, CGM daily mean
CGM138 mg/dL
worsening · +6.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 71 from the failing basin, 18 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.3 next day on high-intake days · n 23
Would not help
- Keep caffeine lowGI +5.2 next day on high-intake days · n 17
- Keep histamine lowGI +4.9 next day on high-intake days · n 21
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.3supporter · 95%
- Caffeine+5.2detractor · 95%
- Histamine load+4.9detractor · 95%
- Simple carbohydrates-1.8no signal · 33%
- Insoluble fibre-1.2no signal · 24%
- Ultra-processed food-0.9no signal · 19%
- Alcohol+0.5no signal · 15%
- Dietary fat load-0.4no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Autonomic recovery ↑25
- WearableResting HR 72 bpm
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.6 · butyrate capacity 50/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 53 ms
- Sleep
- 6.7 h
- Steps
- 7,086
- Resting HR
- 76 bpm
Daily log: GI score 20, nutritional resilience 65, adherence 94.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.